MoSys Inc. (NASDAQ:MOSY), a leader in semiconductor solutions that enable fast, intelligent data access for network and communications systems, is presenting at The Linley Group’s Linley Tech Carrier Conference 2014. The Linley Tech Carrier Conference takes place June 10-11, 2014. MoSys Inc. (NASDAQ:MOSY) weekly performance is -15.41%. On last trading day company shares ended up $2.91. Analysts mean target price for the company is $6.17. MoSys Inc. (NASDAQ:MOSY) distance from 50-day simple moving average (SMA50) is -25.26%.
Mellanox Technologies, Ltd. (NASDAQ:MLNX), a leading supplier of high-performance, end-to-end interconnect solutions for data center servers and storage systems,on 2 June announced the general availability of its Virtual Modular Switch (VMS) Wizard, a new automation software for planning, installing and validating Ethernet Switching fabrics. Mellanox Technologies, Ltd. (NASDAQ:MLNX) shares fell -2.06% in last trading session and ended the day on $30.96. MLNX gross Margin is 65.50% and its return on assets is -3.30%.Mellanox Technologies, Ltd. (NASDAQ:MLNX) quarterly performance is -13.52%.
On May 23, 2014, Ixia (NASDAQ:XXIA) received a letter from The NASDAQ Stock Market LLC indicating that a Nasdaq Hearings Panel had granted the Company’s request to extend the stay of the suspension of trading in the Company’s common stock pending the Company’s scheduled hearing on June 12, 2014 before the Panel and a final determination regarding the Company’s listing status. As previously announced, the Company had requested a hearing regarding the potential delisting of the Company’s common stock and, as part of that request, had also requested that the extended stay be granted. Ixia (NASDAQ:XXIA) shares moved down -0.09% in last trading session and was closed at $11.44, while trading in range of $11.27 – $11.53. Ixia (NASDAQ:XXIA) year to date (YTD) performance is -14.05%.
Transgenomic Inc. (NASDAQ:TBIO) a global biotechnology company advancing personalized medicine in cardiology oncology and inherited diseases through advanced diagnostic tests and clinical and research services on 28 may announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR). Transgenomic Inc. (NASDAQ:TBIO) ended the last trading day at $3.62. Company weekly volatility is calculated as 5.76% and price to cash ratio as 16.61.Transgenomic Inc. (NASDAQ:TBIO) showed a negative weekly performance of -8.12%.
Robbins Geller Rudman & Dowd LLP on 30 may announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Covisint Corporation (NASDAQ:COVS) common stock pursuant and/or traceable to Covisint’s September 26, 2013 initial public stock offering (the “IPO”), seeking to pursue remedies under the Securities Act of 1933 (the “Securities Act”). Covisint Corp (NASDAQ:COVS) net profit margin is -36.70% and weekly performance is -27.48%. On last trading day company shares ended up $4.17. Analysts mean target price for the company is $6.00. Covisint Corp (NASDAQ:COVS) distance from 50-day simple moving average (SMA50) is -39.24%.